SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on February 24, 2021. The filing reports a material event under Item 8.01 (Other Events) regarding the passing of a director.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change reported is the death of Mr. Charles Macaluso, a director of the Company and a member of the Audit Committee, which occurred on February 24, 2021.
Guidance, Outlook, and Risks
The filing does not contain updated guidance, outlook, or management commentary on financial performance. The only risk or contingency noted is the loss of a board member and Audit Committee member.
Key Facts for Investor Verification
- Verify the identity of the registrant: The filing is for Landec Corporation (Ticker: LNDC), not Lifecore Biomedical, Inc.
- Confirm the status of the Audit Committee following the passing of Mr. Charles Macaluso.
- Review the attached press release (Exhibit 99.1) for details on the succession plan or interim board arrangements.